Filing metadata

Accession number
0001209191-20-020934
Form type
Form 3
Filer
VYNE Therapeutics Inc.
CIK
CIK 1566044
Filed
Mar 24, 2020
Reporting period
Mar 23, 2020
Description
Initial ownership

Explore SEC Filings Hub